Josh Rabinowitz
A researcher who discussed intravenous NAD+ on a podcast, noting its effectiveness.
Videos Mentioning Josh Rabinowitz

357 ‒ A new era of longevity science: models of aging, rapamycin trials, biological clocks, & more
Peter Attia MD
A researcher who discussed intravenous NAD+ on a podcast, noting its effectiveness.

#46–Chris Masterjohn, Ph.D.: Pathways to health and disease (NAD, sirtuins, methylation, choline...
Peter Attia MD
Researcher whose animal studies (mice) utilized elegant tracers to track NR metabolism, showing that most NR is converted to nicotinamide by the liver before reaching other tissues as NAD+.

#31 – Navdeep Chandel, Ph.D.: metabolism, mitochondria, and metformin in health and disease
Peter Attia MD
A classmate of Peter Attia from medical school and colleague at Princeton, who published a paper on NAD+ precursors and their uptake by the liver.

#70–David Sinclair, PhD: How cellular reprogramming could slow our aging clock, & the latest on NAD
Peter Attia MD
Professor at Princeton whose lab conducted a tracer study on oral nicotinamide riboside in mice, showing initial conversion to NAD+ primarily in the liver.

#66 – Vamsi Mootha, MD: Aging, T2D, cancer, dementia, Parkinson’s—do all roads lead to mitochondria?
Peter Attia MD
An investigator who independently stumbled upon the discovery of the mitochondrial folate pathway being dramatically upregulated in cancer.